IQVIA Holdings | IQV - Current Liabilities


IQVIA Holdings reported $8.82B in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
Accenture USD 21.61B 651.67M Mar/2026
Agilent USD 2.27B 35M Mar/2026
Bruker USD 1.2B 150.4M Jun/2026
Cardinal Health USD 43.9B 1.92B Jun/2026
Celltrion KRW 292.71B 9.09B Mar/2026
Charles River Laboratories USD 1.13B 41.04M Jun/2026
Cigna USD 55.56B 2.96B Jun/2026
Cognizant Technology Solutions USD 3.46B 56M Jun/2026
Cspc Pharmaceutical CNY 10.18B 65.36M Dec/2025
CVS Health USD 87.04B 635M Jun/2026
Danaher USD 8.1B 645M Jun/2026
Dentsply International USD 1.18B 22M Jun/2026
Deva Holding AS TRY 6.43B 1.18B Sep/2023
Dianthus Therapeutics USD 34.39M 3.89M Jun/2026
Divis Laboratories Ltd INR 20.43B 3.15B Mar/2026
Elevance Health USD 44.25B 1.06B Jun/2026
Humana USD 21.51B 5.16B Mar/2026
IBM USD 35.91B 4.19B Jun/2026
Illumina USD 1.58B 12M Jun/2026
Infosys INR 7.34B 492B Mar/2026
Kangmei Pharma CNY 5.38B 433.79M Mar/2026
Knight Therapeutics CAD 165.26M 12.58M Dec/2025
Laboratorios Farma EUR 199.84M 121.75M Dec/2023
Laboratory Of America USD 2.12B 516.4M Jun/2026
Malin Corporation EUR 1000K 500K Dec/2024
McKesson USD 70.36B 3.34B Jun/2026
Mettler Toledo International USD 1.2B 92.14M Jun/2026
Organigram Holdings CAD 88.74M 5.31M Mar/2026
Ovoca Bio EUR 1.3M 1.11M Dec/2025
Pharma Mar EUR 98.42M 9.2M Jun/2026
Publicis EUR 23.94B 47M Jun/2026
Qiagen NV USD 581.45M 102.34M Jun/2026
Quest Diagnostics USD 1.79B 389M Jun/2026
Revvity USD 1.28B 37.71M Jun/2026
Sartorius EUR 1.44B 668.7M Jun/2026
Sino Biopharmaceutical CNY 24.85B 5.29B Jun/2025
Thermo Fisher Scientific USD 15.07B 448M Jun/2026
Tilray USD 259.32M 8.32M Sep/2025
UnitedHealth USD 111.82B 2.3B Jun/2026
Veeva Systems USD 1.7B 64.71M Mar/2026
Veradigm USD 230.31M 22.78M Dec/2022
Waters USD 2.27B 1.03B Mar/2026
Zealand Pharma A/S 404M 260.96M Mar/2026
Zz Pientze Pharmaceu CNY 2.28B 134.52M Mar/2026